Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Prenatal exposure to antiseizure medications and fetal growth : a population-based cohort study from the Nordic countries

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • Contributors:
      Faculty of Medicine
    • الموضوع:
      2024
    • Collection:
      Opin vísindi (Iceland)
    • نبذة مختصرة :
      Publisher Copyright: © 2024 The Author(s) ; Background: The short- and long-term consequences of restricted fetal growth cause considerable concern, and how prenatal exposure to different antiseizure medications (ASMs) affects fetal growth remains uncertain. Methods: This was a population-based cohort study of liveborn singleton children born in Denmark, Finland, Iceland, Norway, and Sweden from 1996 to 2017. Prenatal exposure was defined as maternal filling of prescriptions for ASM during pregnancy registered in national prescription registries and primary outcomes were adjusted odds ratios (aORs) of microcephaly or being born small for gestational age. Findings: We identified 4,494,918 children (males: 51.3%, 2,306,991/4,494,918), including 38,714 (0.9%) children of mothers with epilepsy. In the overall population, prenatal monotherapy exposure with carbamazepine (aOR: 1.25 (95% CI: 1.12–1.40)), pregabalin (aOR: 1.16 (95% CI: 1.02–1.31)), oxcarbazepine (aOR: 1.48 (95% CI: 1.28–1.71)), clonazepam (aOR: 1.27 (95% CI: 1.10–1.48)), and topiramate (aOR: 1.48 (95% CI: 1.18–1.85)) was associated with risk of being born small for gestational age, and carbamazepine was associated with microcephaly (aOR: 1.43 (95% CI: 1.17–1.75)). In children of mothers with epilepsy, prenatal exposure to carbamazepine (aOR: 1.27 (95% CI: 1.11–1.47)), oxcarbazepine (aOR: 1.42 (95% CI: 1.18–1.70)), clonazepam (aOR: 1.40 (95% CI: 1.03–1.89)), and topiramate (aOR: 1.86 (95% CI: 1.36–2.54)) was associated with being born small for gestational age; carbamazepine, with microcephaly (aOR: 1.51 (95% CI: 1.17–1.95)). No associations with small for gestational age and microcephaly were identified after prenatal exposure to lamotrigine, valproate, gabapentin, levetiracetam, phenobarbital, acetazolamide, phenytoin, clobazam, primidone, zonisamide, vigabatrin, ethosuximide and lacosamide, but except for lamotrigine, valproate, gabapentin, and levetiracetam, numbers of exposed children were small. Interpretation: Prenatal exposure to carbamazepine, ...
    • ISSN:
      2666-7762
    • Relation:
      The Lancet Regional Health - Europe; 38(); http://www.scopus.com/inward/record.url?scp=85186609776&partnerID=8YFLogxK; Christensen , J , Zoega , H , Leinonen , M K , Gilhus , N E , Gissler , M , Igland , J , Sun , Y , Tomson , T , Alvestad , S , Bjørk , M H & Dreier , J W 2024 , ' Prenatal exposure to antiseizure medications and fetal growth : a population-based cohort study from the Nordic countries ' , The Lancet Regional Health - Europe , vol. 38 , 100849 . https://doi.org/10.1016/j.lanepe.2024.100849; 219058090; 5219d32b-f398-4a7a-92c8-508424956a49; 85186609776; https://hdl.handle.net/20.500.11815/4817
    • الرقم المعرف:
      10.1016/j.lanepe.2024.100849
    • Rights:
      info:eu-repo/semantics/openAccess
    • الرقم المعرف:
      edsbas.FAAD04F5